0001814544-20-000001.txt : 20200610 0001814544-20-000001.hdr.sgml : 20200610 20200610143529 ACCESSION NUMBER: 0001814544-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 EFFECTIVENESS DATE: 20200610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cullinan Mica Corp. CENTRAL INDEX KEY: 0001814544 IRS NUMBER: 811023336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368655 FILM NUMBER: 20954459 BUSINESS ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-750-4700 MAIL ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001814544 Cullinan Mica Corp. 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA CALIFORNIA 92037 858-750-4700 DELAWARE PDI Therapeutics, Inc. None Corporation true 2016 Neil W. Gibson, Ph.D. c/o Cullinan Mica Corp. 11099 North Torrey Pines Road La Jolla CA CALIFORNIA 92037 Executive Officer Director Jay B. Lichter c/o Cullinan Mica Corp. 11099 North Torrey Pines Road La Jolla CA CALIFORNIA 92037 Director Owen Hughes One Main Street, Suite 520 Cambridge MA MASSACHUSETTS 02142 Director Morana Jovan-Embiricos One Main Street, Suite 520 Cambridge MA MASSACHUSETTS 02142 Director Anthony Rosenberg One Main Street, Suite 250 Cambridge MA MASSACHUSETTS 02142 Director Pharmaceuticals Decline to Disclose 06b false 2020-05-28 false true false 0 34588641 16588638 18000003 Total Offering Amount and Total Amount Sold includes amounts paid pursuant to conversion of indebtedness. false 4 0 0 0 false Cullinan Mica Corp. /s/ Neil W. Gibson, Ph.D. Neil W. Gibson, Ph.D. President and CEO 2020-06-10